Full patient enrolment in Phase IIa Menstrual Migraine study
Asarina Pharma AB has reached full patient enrolment in its Phase IIa menstrual migraine (MM) study. 158 women have been...
Read More
Asarina Pharma AB has reached full patient enrolment in its Phase IIa menstrual migraine (MM) study. 158 women have been...
Read MoreWomen receiving fertility-sparing surgery for treatment of borderline ovarian tumours were able to have children, a study from Karolinska Institutet...
Read MoreThe small blood vessels in muscles of women after menopause are less able to grow compared to young women, according to...
Read MoreFrom the website: The first of the 2021 series of 6 UK and Ireland live and online gatherings of midwifery...
Read MoreThe suspension of fertility treatments due to the COVID-19 pandemic has had a variety of psychological impacts on women whose...
Read MoreNew research helps explain why flu can lead to life-threatening complications during pregnancy, suggesting the virus does not stay in...
Read MoreSecond-year midwifery student Marie Layne reflects on her placement, which took place during the pandemic. Marie took a long time...
Read MoreBeing older, overweight, and having other medical conditions increase their risk of having more serious disease Pregnant women seen in...
Read MoreObs Gynae & Midwifery News (OGMN) is a leading trade title in the field of obstetrics, gynaecology, midwifery and women’s health
Having been at the forefront of this critical field for over a decade as its leading trade title, Obs Gynae & Midwifery News is now an exclusively digital platform.